2021 DPA Webinar Series | Session 3

Applications of Digital Pathology & Artificial Intelligence in Toxicologic Pathology


Wednesday, June 16 | 11 AM - 12 PM Eastern


A significant number of the American College of Veterinary Pathologists (ACVP) pathologists are dedicated to the integration of toxicologic pathology into hazard identification and risk assessment/communication regarding human and animal exposure to potentially toxic substances, including drug products and medical devices. There has not been broad adoption of digital pathology in the field of toxicologic pathology, particularly in the context of regulatory studies, due to lack of adapted regulatory guidance and precedence. In this presentation, the speakers will highlight challenges and minimal requirements needed to gain future regulatory acceptance for the use of digital toxicologic pathology workflows in drug discovery and development. Furthermore, a holistic deep learning model trained on normal tissues from preclinical species and its application in toxicologic pathology will be discussed.




Manu Sebastian, DVM, PhD

Associate Professor, Department of Epigenetics and Molecular Carcinogenesis

University of Texas MD Anderson Cancer Center




BoisclairJulie Boisclair, DVM, DES, MSc, Diplomate ACVP, Diplomate ABT

Head, Project Pathology EU, Preclinical Safety

Novartis Institutes for BioMedical Research




MoulinPierre Moulin, MD, PhD

Director, Pathology, Preclinical safety, Translational Medicine

Project Lead IMI-BigPicture

Novartis Institutes for BioMedical Research



SaravananChandra Saravanan, DVM, MS, PhD, Diplomate ACVP

Director, Discovery & Investigative Safety, Preclinical Safety,

Novartis Institutes for BioMedical Research 






Registration Level